Pink Sheet Posts Analysis on ‘Muted’ J.P. Morgan Coference
January 22, 2020
The Pink Sheet in a recent analysis takes a look at J.P. Morgan’s recent conference on health care at which the big elephant in the room was drug pricing.
According to the report, the industry is heavily focused on the execution of “focused strategies.”
To read more, click here. (Paid subscription required)
